The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences announced a collaborative project to build a large single-cell atlas of cancer plasticity. By analyzing hundreds of millions of cells from 3D organoid cultures, this resource will enable computational modeling of tumor responses and mechanisms underlying cancer adaptability to treatments. The work supports advances in precision oncology by elucidating cellular heterogeneity and resistance pathways.